The prevalence and potential associations of anti-drug antibodies against adalimumab in patients with non-infectious uveitis: a cross-sectional study.

J Ophthalmic Inflamm Infect · 2025 · PMC12847475 · PMID 41447414

Europe PMC DOI

hedged sentence

0.6190

closest p · 12.4× alpha

0.6190

boldest claim

The sentences

did not reach statistical significancep = 0.619not close (p > 0.1)

With respect to the impact of ADA-A on clinical disease activity, we observed a trend towards a higher proportion of patients with ADA-A having active uveitis, but this did not reach statistical significance [2/5 (40%) vs. 21/76 (28%), p = 0.619].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.